Literature DB >> 30174940

Accumulation of periostin in acute exacerbation of familial idiopathic pulmonary fibrosis.

Keisuke Murata1, Yasuhiko Koga1, Norimitsu Kasahara1, Yoshimasa Hachisu1, Satoshi Nunomura2, Nozomi Nakajima3, Hideaki Yokoo3, Kyoichi Kaira4, Toshitaka Maeno1, Kunio Dobashi5, Kenji Izuhara2, Takeshi Hisada1.   

Abstract

Periostin, an extracellular matrix molecule, is associated with idiopathic pulmonary fibrosis (IPF). It is known that the frequency of familial IPF (FIPF) ranges from 0.5% to 2.2% among IPF cases. However, the relationship between periostin and FIPF has not been previously described. We report the first case of periostin accumulation in the lungs of a patient with an acute exacerbation of FIPF. A 72-year-old woman, diagnosed with FIPF, had been followed up for 5 years. The patient experienced increased dyspnea within a 1-month period and was referred to our hospital. The patient was hypoxic, and chest computed tomography showed rapidly expanding bilateral reticular shadows. Despite pulse-steroid and intravenous-cyclophosphamide therapy, the patient died 25 days after admission. On admission, serum periostin levels were not significantly elevated, while serum fibrotic marker levels were elevated. Immunohistochemical analysis of the lungs on autopsy showed marked accumulation of periostin in the active fibrotic lesions, whereas intact and burned-out areas did not show significant expression of periostin. This case might provide insight into the role of periostin in acute exacerbation of IPF.

Entities:  

Keywords:  Familial idiopathic pulmonary fibrosis (FIPF); acute exacerbation (AE); idiopathic interstitial pneumonia; periostin

Year:  2018        PMID: 30174940      PMCID: PMC6105951          DOI: 10.21037/jtd.2018.06.96

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  8 in total

Review 1.  Roles of Periostin in Respiratory Disorders.

Authors:  Kenji Izuhara; Simon J Conway; Bethany B Moore; Hisako Matsumoto; Cecile T J Holweg; John G Matthews; Joseph R Arron
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

2.  Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis.

Authors:  K Kou; T Okawa; Y Yamaguchi; J Ono; Y Inoue; M Kohno; S Matsukura; T Kambara; S Ohta; K Izuhara; M Aihara
Journal:  Br J Dermatol       Date:  2014-08-05       Impact factor: 9.302

3.  Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.

Authors:  M Okamoto; T Hoshino; Y Kitasato; Y Sakazaki; T Kawayama; K Fujimoto; K Ohshima; H Shiraishi; M Uchida; J Ono; S Ohta; S Kato; K Izuhara; H Aizawa
Journal:  Eur Respir J       Date:  2010-12-22       Impact factor: 16.671

4.  Familial idiopathic pulmonary fibrosis: clinical features and outcome.

Authors:  Hong-Lyeol Lee; Jay H Ryu; Michael H Wittmer; Thomas E Hartman; James F Lymp; Henry D Tazelaar; Andrew H Limper
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

5.  Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.

Authors:  Motoki Natsuizaka; Hirofumi Chiba; Koji Kuronuma; Mitsuo Otsuka; Kazumi Kudo; Mitsuru Mori; Masashi Bando; Yukihiko Sugiyama; Hiroki Takahashi
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

6.  High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia.

Authors:  Ho Yun Lee; Joon Beom Seo; Mark P Steele; Marvin I Schwarz; Kevin K Brown; James E Loyd; Janet L Talbert; David A Schwartz; David A Lynch
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

Review 7.  Periostin in allergic inflammation.

Authors:  Kenji Izuhara; Kazuhiko Arima; Shoichiro Ohta; Shoichi Suzuki; Masako Inamitsu; Ken-ichi Yamamoto
Journal:  Allergol Int       Date:  2014-03-25       Impact factor: 5.836

8.  The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.

Authors:  Shoichiro Ohta; Masaki Okamoto; Kiminori Fujimoto; Noriho Sakamoto; Koichiro Takahashi; Hiroshi Yamamoto; Hisako Kushima; Hiroshi Ishii; Keiichi Akasaka; Junya Ono; Ayami Kamei; Yoshinori Azuma; Hisako Matsumoto; Yukie Yamaguchi; Michiko Aihara; Takeshi Johkoh; Atsushi Kawaguchi; Masao Ichiki; Hironori Sagara; Jun-Ichi Kadota; Masayuki Hanaoka; Shin-Ichiro Hayashi; Shigeru Kohno; Tomoaki Hoshino; Kenji Izuhara
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

  8 in total
  4 in total

1.  Can serum periostin predict bronchopulmonary dysplasia in premature infants?

Authors:  Hayato Go; Junya Ono; Hitoshi Ohto; Kenneth E Nollet; Kenichi Sato; Yohei Kume; Hajime Maeda; Mina Chishiki; Kentaro Haneda; Hirotaka Ichikawa; Nozomi Kashiwabara; Yuji Kanai; Kei Ogasawara; Maki Sato; Koichi Hashimoto; Satoshi Nunomura; Kenji Izuhara; Mitsuaki Hosoya
Journal:  Pediatr Res       Date:  2021-12-27       Impact factor: 3.953

2.  Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat.

Authors:  Tejaswini Kulkarni; Steven R Duncan
Journal:  Curr Pulmonol Rep       Date:  2019-11-26

3.  Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer.

Authors:  Hiroyuki Yamato; Kenji Kimura; Eriko Fukui; Takashi Kanou; Naoko Ose; Soichiro Funaki; Masato Minami; Yasushi Shintani
Journal:  Sci Rep       Date:  2021-10-26       Impact factor: 4.379

Review 4.  Periostin in Allergy and Inflammation.

Authors:  Eva Sonnenberg-Riethmacher; Michaela Miehe; Dieter Riethmacher
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.